Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Neuroblastoma 3Medulloblastoma 3Rhabdomyosarcoma 2Rhabdoid Tumor 2Meningeal Carcinomatosis 2Wilms Tumor 1Sarcoma, Ewing 1Sarcoma 1Retinoblastoma 1Pinealoma 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors, Primitive 1Meningeal Neoplasms 1Hepatoblastoma 1Ependymoma 1Desmoplastic Small Round Cell Tumor 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Filgrastim 8Granulocyte Colony-Stimulating Factor 7Thiotepa 6Etoposide 5Carboplatin 5Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4Busulfan 4Melphalan 3Ifosfamide 3Topotecan 2Mesna 2sargramostim 1racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1etoposide phosphate 1cixutumumab 1becatecarin 1alvocidib 1Vincristine 1Ursodeoxycholic Acid 1Thrombopoietin 1Thalidomide 1Temozolomide 1Stem Cell Transplantation 1Sirolimus 1Simvastatin 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Retinoblastoma × omburtamab I-131 × CNS × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡